IL17RB and neoplasm: Moreover, IL-17RB-mediated secretion of soluble factors will ultimately reshape the tumor microenvironment toward a macrophage-enriched infiltrate that might impair the anti-tumor immune response and favor resistance to treatments (Figure 1).